BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases (Q35987052)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases (English)

1 reference

Europe PubMed Central

11 August 2017

cardiovascular disease

1 reference

based on heuristic

inferred from title

Gregg C. Fonarow

9

object named as

Gregg Fonarow

1 reference

Europe PubMed Central

11 August 2017

3

object named as

Clyde W Yancy

1 reference

Europe PubMed Central

11 August 2017

Mandeep R. Mehra

7

object named as

Mandeep R Mehra

1 reference

Europe PubMed Central

11 August 2017

author name string

Marc A Silver

1

1 reference

Europe PubMed Central

11 August 2017

Alan Maisel

2

1 reference

Europe PubMed Central

11 August 2017

Peter A McCullough

4

1 reference

Europe PubMed Central

11 August 2017

John C Burnett

5

1 reference

Europe PubMed Central

11 August 2017

Gary S Francis

6

1 reference

Europe PubMed Central

11 August 2017

William Franklin Peacock

8

1 reference

Europe PubMed Central

11 August 2017

W Brian Gibler

10

1 reference

Europe PubMed Central

11 August 2017

David A Morrow

11

1 reference

Europe PubMed Central

11 August 2017

Judd Hollander

12

1 reference

Europe PubMed Central

11 August 2017

BNP Consensus Panel

13

1 reference

Europe PubMed Central

11 August 2017

publication date

1 September 2004

1 reference

Europe PubMed Central

11 August 2017

Congestive Heart Failure

1 reference

Europe PubMed Central

11 August 2017

10

1 reference

Europe PubMed Central

11 August 2017

5 Suppl 3

1 reference

Europe PubMed Central

11 August 2017

1-30

1 reference

Europe PubMed Central

11 August 2017

Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Quality of care for elderly patients hospitalized with heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

B-type natriuretic peptide levels: a potential novel "white count" for congestive heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Plasma brain natriuretic peptide concentration: impact of age and gender

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Promises and perils of managed care for older patients with cardiac disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Measurement and importance of plasma brain natriuretic peptide and related peptides

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Effects of prehospital medications on mortality and length of stay in congestive heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Plasma brain natriuretic peptide in assessment of acute dyspnoea.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Uncovering Heart Failure in Patients with a History of Pulmonary Disease: Rationale for the Early Use of B-type Natriuretic Peptide in the Emergency Department

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Diagnostic value of B-Type natriuretic peptide and chest radiographic findings in patients with acute dyspnea

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Brain Natriuretic Peptide as a Predictor of Adverse Outcome in Patients With Pulmonary Embolism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Clinical significance of brain natriuretic peptide in primary pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Relation of duration of morbid obesity to left ventricular mass, systolic function, and diastolic filling, and effect of weight loss

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Obesity and the risk of heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Expression of natriuretic peptide receptors in human adipose and other tissues.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Obesity and suppressed B-type natriuretic peptide levels in heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Impact of obesity on plasma natriuretic peptide levels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Preliminary data on the potential usefulness of B-type natriuretic peptide levels in predicting outcome after hospital discharge in patients with heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

B-type natriuretic peptide predicts sudden death in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Usefulness of brain natriuretic peptide release as a surrogate marker of the efficacy of long-term cardiac resynchronization therapy in patients with heart failure.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Biventricular pacing diminishes the need for implantable cardioverter defibrillator therapy. Ventak CHF Investigators

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Plasma natriuretic peptide levels and the risk of cardiovascular events and death

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Readmission after hospitalization for congestive heart failure among Medicare beneficiaries.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Clinical cardiovascular databases: ready for prime time?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Tailored therapy to hemodynamic goals for advanced heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Usefulness of B-type natriuretic peptide levels in predicting hemodynamic perturbations after heart transplantation despite preserved left ventricular systolic function.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Transient reduction without normalization of brain natriuretic peptide early after heart transplantation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Intravenous nesiritide (human B-type natriuretic peptide) reduces plasma endothelin-1 levels in patients with decompensated congestive heart failure.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Endothelin-1 and endothelin receptor antagonists in cardiovascular remodeling

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Molecular biology of the natriuretic peptides and their receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Inhibition of aldosterone production in the adrenal glomerulosa by atrial natriuretic factor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Inotropic infusions for chronic congestive heart failure: medical miracles or misguided medicinals?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Hemodynamic and hormonal effects of high-dose transdermal nitroglycerin in patients with chronic congestive heart failure.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Neurohormonal activation, the renal dopaminergic system and sodium handling in patients with severe heart failure under vasodilator therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

The efficacy and safety of B-type natriuretic peptide (nesiritide) in patients with renal insufficiency and acutely decompensated congestive heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Cardiac fibrosis in mice lacking brain natriuretic peptide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Gene Expression, Secretion, and Autocrine Action of C-Type Natriuretic Peptide in Cultured Adult Rat Cardiac Fibroblasts

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Economic implications of nesiritide versus dobutamine in the treatment of patients with acutely decompensated congestive heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Subcutaneous administration of brain natriuretic peptide in experimental heart failure.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Sustained reduction of aldosterone in response to the angiotensin receptor blocker valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Significance of Raised Natriuretic Peptides After Bicaval and Standard Cardiac Transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03271.X

21 January 2018

Identifiers

10.1111/J.1527-5299.2004.03271.X

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35987052&oldid=1703963444"